President-elect Barack Obama's plan to overhaul the healthcare system, if it comes to pass, would have mixed implications for the healthcare industry, says Moody's Investors Service.
As outlined during the campaign, Mr. Obama's plan would likely benefit healthcare providers due to an increase in customers, but could put downward pressure on the credit profiles of pharmaceutical companies and healthcare insurers, due to cost-cutting measures outlined in the plan, according to the ratings agency.
"If a plan like what President-elect Obama has proposed were to be enacted, more consumers would have access to the healthcare system on an insured basis," says Moody's Costas Chrysostomou, a healthcare analyst with the agency's Corporate Finance Group. "While this is expected to benefit healthcare providers, cost-cutting initiatives proposed to fund the plan pose some challenges for drug companies and insurance providers."
The full Special Comment, titled U.S. Healthcare Industry: Credit Implications of the U.S. Election, is available on www.moodys.com.